Cresco Labs Inc. (CL)
CSE
Closed
Aug 25, 2026
Day's Range
1.0652 wk Range
0.8900Overview - CL - Cresco Labs Inc.
Key Statistics
Valuation
Enterprise Value
1.21B
P/E (Trailing)
‪-2.78‬
P/E (Forward)
‪-19.16‬
PEG Ratio
‪0.01‬
Price / Sales (TTM)
‪0.64‬
Price / Book
‪0.84‬
EV / EBITDA
‪7.95‬
Profitability
Gross Margin
‪50.15%‬
Profit Margin
‪-15.49%‬
Operating Margin
‪7.70%‬
Return on Assets
‪2.99%‬
Return on Equity
‪-36.06%‬
Ownership
Shares Outstanding
370.49M
Float
346.24M
Short % of Shares Outstanding
‪0.00%‬
Held by Insiders
‪2.05%‬
Held by Institutions
‪3.45%‬
Price stats
Beta
‪1.72‬
50-Day Avg
‪1.07‬
200-Day Avg
‪1.32‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪CA$ 2.50‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CL - Cresco Labs Inc.
Peers - CL - Cresco Labs Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on CSE.
Profile Summary - CL - Cresco Labs Inc.
About
Cresco Labs Inc. is a prominent entity within the cannabis industry, specializing in the cultivation, manufacturing, and sale of cannabis products. Known for its vertically integrated structure, the company's operations encompass the entire spectrum of cannabis production, from cultivation to retail distribution.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
